April 03, 2025

Oophorectomy May Elevate Heart Failure Risk

Bilateral ovary removal may increase heart failure risk 1.5-fold, with White women and younger patients facing double the risk, according to new research presented at ACC.25.

Conexiant

April 03, 2025

FDA Reaches Decision on Reproxalap

The FDA’s Complete Response Letter recommends an additional trial that focuses on DED symptoms.

Conexiant

April 02, 2025

HPV Testing Guidelines Updated for Head and Neck Carcinomas

New evidence expands recommendations for sinonasal squamous cell carcinoma and standardizes p16 immunohistochemistry interpretation.

Conexiant

April 02, 2025

Maternal Depression Affects Child's Eating Patterns

Early maternal depressive symptoms may hinder children's self-regulation and eating behaviors, according to a recent study.

Conexiant

April 02, 2025

Donanemab: Amyloid-Related Imaging Abnormalities

"ARIA is an adverse event associated with donanemab treatment that requires safety monitoring."

Conexiant

April 02, 2025

FDA Approves Automated Latent TB Test

Revvity’s Auto-Pure 2400 platform for use with the T-SPOT.TB test to automate latent tuberculosis diagnostics was approved by the FDA.

Conexiant

April 02, 2025

Sleep Apnea Associated with Lung Cancer Risk

The impact of sleep apnea on lung cancer risk appears to be strongly influenced by biological sex, researchers find in a nationwide study of COPD patients.

Conexiant

April 02, 2025

Herpes Zoster Vaccine May Lower Dementia Risk

"If these findings are truly causal, the zoster vaccine will be both far more effective as well as cost-effective in preventing or delaying dementia."

Conexiant

April 01, 2025

GEM Helps Put T2D in Remission

Researchers highlight evidence-based lifestyle and pharmacologic strategies, including glycemic excursion minimization and tirzepatide, for early glycemic control in adults with type 2 diabetes.

Conexiant